Cite
Advancing Precision Oncology Through Biomarker-Driven Trials: Theory vs. Practice.
MLA
Halabi, Susan, and Donna Niedzwiecki. “Advancing Precision Oncology Through Biomarker-Driven Trials: Theory vs. Practice.” Chance, vol. 32, no. 4, Nov. 2019, pp. 23–31. EBSCOhost, https://doi.org/10.1080/09332480.2019.1695438.
APA
Halabi, S., & Niedzwiecki, D. (2019). Advancing Precision Oncology Through Biomarker-Driven Trials: Theory vs. Practice. Chance, 32(4), 23–31. https://doi.org/10.1080/09332480.2019.1695438
Chicago
Halabi, Susan, and Donna Niedzwiecki. 2019. “Advancing Precision Oncology Through Biomarker-Driven Trials: Theory vs. Practice.” Chance 32 (4): 23–31. doi:10.1080/09332480.2019.1695438.